,4 Among patients with autoimmune diseases, especially rheumatoid arthritis (RA), the prevalence of DILD is 0.3-11.0% in those treated with methotrexate and 0.5-3.0% in those treated with anti-TNF agents.5 The gene discussed is TNF; the disease is rheumatoid arthritis.